Mantomed

Memantine Hydrochloride, the active ingredient in Mantomed, is a non‑competitive NMDA receptor antagonist presented as an oral dosage form for oral administration. It works by reducing excitotoxic neuronal damage and is indicated for the treatment of moderate to severe Alzheimer’s disease in adult patients, helping to preserve cognitive function and daily living activities.

GNH USA supplies Mantomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides reliable global logistics for regulated medicines.

Mantomed (memantine hydrochloride) is used in the management of neurodegenerative conditions that involve glutamatergic excitotoxicity, primarily Alzheimer’s disease.

Alzheimer’s disease: improves cognition, functional abilities, and slows progression of symptoms in moderate to severe stages.

Common and serious adverse reactions have been reported with memantine therapy.

Common Side Effects: - Dizziness - Headache - Constipation - Fatigue

Serious or Rare Side Effects: - Seizures - Severe allergic reactions (rash, angioedema) - Hallucinations or psychosis

Before initiating Mantomed, several safety considerations should be reviewed. - Renal impairment: adjust dose or monitor renal function. - History of seizures: assess risk before initiating therapy. - Concomitant use with other NMDA antagonists: avoid due to additive effects. - Cardiovascular disease: monitor for arrhythmias. - Pregnancy and lactation: safety not established; use only if clearly needed. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Memantine may interact with several medicines; clinical judgment is required.

Major Interactions (Avoid): - Amantadine: may increase risk of neuropsychiatric effects. - Ketamine: additive NMDA antagonism can exacerbate CNS depression.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may worsen cognitive side effects. - CNS depressants (e.g., benzodiazepines): monitor for increased sedation. - Diuretics (e.g., furosemide): may raise memantine plasma levels.